RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
0 hedge funds and large institutions have $0 invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 111 closing their positions.
100% less funds holding
Funds holding: 111 → 0 (-111)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $468M → $0 (-$468M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 111
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$36.4M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$35.6M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$34.1M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$31.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$30.7M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CG
101
Cutler Group
San Francisco,
California
| – | -$54K | -6,126 | Closed |
|
102
BNP Paribas Financial Markets
Paris,
France
| – | -$53.4K | -5,953 | Closed |
|
103
Creative Planning
Overland Park,
Kansas
| – | -$45K | -5,000 | Closed |
|
104
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$31K | -3,454 | Closed |
|
|
AIM
105
Acrospire Investment Management
Chicago,
Illinois
| – | -$31K | -3,451 | Closed |
|
|
JG
106
Jefferies Group
New York
| – | -$27K | -3,000 | Closed |
|
|
BJ
107
BlackRock Japan
Tokyo,
Japan
| – | -$25K | -2,811 | Closed |
|
108
UBS Group
Zurich,
Switzerland
| – | -$19K | -2,100 | Closed |
|
|
TRCT
109
Tower Research Capital (TRC)
New York
| – | -$4K | -447 | Closed |
|
|
GT
110
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$1K | -141 | Closed |
|
RPTP Hedge Fund Activity: Q4 2016 in Review
0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q4 2016, worth a combined $0 — down 100% from $468M a quarter earlier.
Sellers outnumbered buyers: 111 funds closed out of RPTP and 0 opened new positions — a net loss of 111 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was AQR Arbitrage, exiting entirely with an estimated $36.4M sold.
- 0 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q4 2016, down from 111 in Q3 2016.
- Funds reported $0 of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q4 2016 and 111 closed out, a net change of -111 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q4 2016 was AQR Arbitrage, an estimated $36.4M sold.
Based on aggregated 13F filings for Q4 2016.